The global diphtheria vaccine market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of cases of diphtheria and the need for vaccination against it. Diphtheria is an acute infectious disease caused by Corynebacterium diphtheriae, which affects the respiratory system and can lead to death if not treated properly. It can be prevented by immunization with DTaP vaccine, which protects against three diseases: diphtheria, tetanus, and pertussis (whooping cough). The DTaP vaccine has been in use since 1949 and has been used in more than 200 countries worldwide.
- The Diphtheria vaccine is a vaccine that protects against diphtheria, a serious bacterial infection.
- The Diphtheria vaccine is given as an injection into the upper arm or thigh muscle and provides protection for 10 years or more.
- The Diphtheria vaccine is recommended for children between 6 weeks and 6 years old, adults who are at increased risk of contracting the disease, and people who have close contact with those at high risk of contracting the disease.
- In 2016, there were only 5 cases of diphtheria in the United States.
- In 2017, there were only 2 cases of diphtheria in the United States.
Industry Growth Insights published a new data on “Diphtheria Vaccine Market”. The research report is titled “Diphtheria Vaccine Market research by Types (DTaP, DT, Td, Tdap), By Applications (For infants and children younger than seven years of age, For adolescents and adults), By Players/Companies GlaxoSmithKline, Sanofi Pasteur, Wyeth (Pfizer), Merck, Novartis, Beijing Tiantan Biological Products, Shanghai Institute of Biological Products, Wuhan Institute of Biological Products, Chengdu Institute of Biological Products, Changchun Changsheng Life Sciences”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Diphtheria Vaccine Market Research Report
By Type
DTaP, DT, Td, Tdap
By Application
For infants and children younger than seven years of age, For adolescents and adults
By Companies
GlaxoSmithKline, Sanofi Pasteur, Wyeth (Pfizer), Merck, Novartis, Beijing Tiantan Biological Products, Shanghai Institute of Biological Products, Wuhan Institute of Biological Products, Chengdu Institute of Biological Products, Changchun Changsheng Life Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Diphtheria Vaccine Market Report Segments:
The global Diphtheria Vaccine market is segmented on the basis of:
Types
DTaP, DT, Td, Tdap
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
For infants and children younger than seven years of age, For adolescents and adults
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Sanofi Pasteur
- Wyeth (Pfizer)
- Merck
- Novartis
- Beijing Tiantan Biological Products
- Shanghai Institute of Biological Products
- Wuhan Institute of Biological Products
- Chengdu Institute of Biological Products
- Changchun Changsheng Life Sciences
Highlights of The Diphtheria Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DTaP
- DT
- Td
- Tdap
- By Application:
- For infants and children younger than seven years of age
- For adolescents and adults
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diphtheria Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diphtheria vaccine is a vaccine that helps protect people from diphtheria. It works by helping the body build immunity to the diphtheria bacteria. Diphtheria vaccine can help prevent the disease if it is given in time.
Some of the major players in the diphtheria vaccine market are GlaxoSmithKline, Sanofi Pasteur, Wyeth (Pfizer), Merck, Novartis, Beijing Tiantan Biological Products, Shanghai Institute of Biological Products, Wuhan Institute of Biological Products, Chengdu Institute of Biological Products, Changchun Changsheng Life Sciences.
The diphtheria vaccine market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Diphtheria Vaccine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Diphtheria Vaccine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Diphtheria Vaccine Market - Supply Chain
4.5. Global Diphtheria Vaccine Market Forecast
4.5.1. Diphtheria Vaccine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Diphtheria Vaccine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Diphtheria Vaccine Market Absolute $ Opportunity
5. Global Diphtheria Vaccine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Diphtheria Vaccine Market Size and Volume Forecast by Type
5.3.1. DTaP
5.3.2. DT
5.3.3. Td
5.3.4. Tdap
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Diphtheria Vaccine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Diphtheria Vaccine Market Size and Volume Forecast by Application
6.3.1. For infants and children younger than seven years of age
6.3.2. For adolescents and adults
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Diphtheria Vaccine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Diphtheria Vaccine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Diphtheria Vaccine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Diphtheria Vaccine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Diphtheria Vaccine Demand Share Forecast, 2019-2026
9. North America Diphtheria Vaccine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Diphtheria Vaccine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Diphtheria Vaccine Market Size and Volume Forecast by Application
9.4.1. For infants and children younger than seven years of age
9.4.2. For adolescents and adults
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Diphtheria Vaccine Market Size and Volume Forecast by Type
9.7.1. DTaP
9.7.2. DT
9.7.3. Td
9.7.4. Tdap
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Diphtheria Vaccine Demand Share Forecast, 2019-2026
10. Latin America Diphtheria Vaccine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Diphtheria Vaccine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Diphtheria Vaccine Market Size and Volume Forecast by Application
10.4.1. For infants and children younger than seven years of age
10.4.2. For adolescents and adults
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Diphtheria Vaccine Market Size and Volume Forecast by Type
10.7.1. DTaP
10.7.2. DT
10.7.3. Td
10.7.4. Tdap
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Diphtheria Vaccine Demand Share Forecast, 2019-2026
11. Europe Diphtheria Vaccine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Diphtheria Vaccine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Diphtheria Vaccine Market Size and Volume Forecast by Application
11.4.1. For infants and children younger than seven years of age
11.4.2. For adolescents and adults
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Diphtheria Vaccine Market Size and Volume Forecast by Type
11.7.1. DTaP
11.7.2. DT
11.7.3. Td
11.7.4. Tdap
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Diphtheria Vaccine Demand Share, 2019-2026
12. Asia Pacific Diphtheria Vaccine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Diphtheria Vaccine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Diphtheria Vaccine Market Size and Volume Forecast by Application
12.4.1. For infants and children younger than seven years of age
12.4.2. For adolescents and adults
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Diphtheria Vaccine Market Size and Volume Forecast by Type
12.7.1. DTaP
12.7.2. DT
12.7.3. Td
12.7.4. Tdap
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Diphtheria Vaccine Demand Share, 2019-2026
13. Middle East & Africa Diphtheria Vaccine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Diphtheria Vaccine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Diphtheria Vaccine Market Size and Volume Forecast by Application
13.4.1. For infants and children younger than seven years of age
13.4.2. For adolescents and adults
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Diphtheria Vaccine Market Size and Volume Forecast by Type
13.7.1. DTaP
13.7.2. DT
13.7.3. Td
13.7.4. Tdap
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Diphtheria Vaccine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Diphtheria Vaccine Market: Market Share Analysis
14.2. Diphtheria Vaccine Distributors and Customers
14.3. Diphtheria Vaccine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GlaxoSmithKline
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sanofi Pasteur
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Wyeth (Pfizer)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Merck
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Novartis
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Beijing Tiantan Biological Products
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Shanghai Institute of Biological Products
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Wuhan Institute of Biological Products
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Chengdu Institute of Biological Products
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Changchun Changsheng Life Sciences
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
